COMPOSÉS 2,3-DIHYDROQUINAZOLINE EN TANT QU'INHIBITEURS DE NAV1.8

The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X):wherein Y′, X′, B′, R1′, R2′, R3′, R5′, R6′, R7′, and z1 are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding pharmaceutical compositions or formulations,...

Full description

Saved in:
Bibliographic Details
Main Authors ELBAN, Mark, HOANG, Tram H, MILLER, William H, VIMAL, Mythily, WASHBURN, David G, GUANG, Jie, YING, Maben, DAVIS, Roderick S, HO, Ming-Hsun, ROMANO, Joseph J
Format Patent
LanguageFrench
Published 04.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to Nav1.8 Inhibitor 2,3-dihydroquinazolin compounds of Formula (X):wherein Y′, X′, B′, R1′, R2′, R3′, R5′, R6′, R7′, and z1 are as defined herein; or pharmaceutically acceptable salts or tautomer forms thereof, corresponding pharmaceutical compositions or formulations, methods or processes of compound preparation, methods, compounds for use in, uses for and/or combination therapies for treating pain and/or pain-related or associated disease(s), disorder(s) or condition(s), respectively.
Bibliography:Application Number: MA20200056398